Mathilde Marchand

2.0k citations
24 papers · 1.5k · 2 hit papers · h-index 13

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
  • Neurology top 5%
    • Long-Term Effects of COVID-19

Papers in

    • Cancer Immunotherapy and Biomarkers 8
    • CAR-T cell therapy research 2
    • Pancreatic and Hepatic Oncology Research 2
    • Colorectal Cancer Treatments and Studies 2
    • Immunotherapy and Immune Responses 2
    • Biosimilars and Bioanalytical Methods 2

Mathilde Marchand

24 papers receiving 1.5k citations

Mathilde Marchand's Hit Papers

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial 2021 · 229 citations
2290+2+4Years since publication100200300400500

Peers

Mathilde Marchand
Comparison fields: 5 of 89
  • Infectious Diseases 642
  • Neurology 319
  • Oncology 362
  • Critical Care and Intensive Care Medicine 44
  • Immunology 165
Replace Oliver Cohen with:
Oliver Cohen United Kingdom
Ayush Arya United States
Ceri H. Jones United Kingdom
Sara R. Schoenfeld United States
Pankti D. Reid United States
Gail Miflin United Kingdom
Lola‐Jade Palmieri France
Paul Legendre France
Olivier Hinschberger France
Antonio Russo Italy
Mathilde Marchand relative to Oliver Cohen United Kingdom Oliver Cohen's profile →
Citations per field
00.5×2×2.5×
Oliver Cohen · 1×
Citations per year

Countries citing papers authored by Mathilde Marchand

Since Specialization
Citations

This map shows the geographic impact of Mathilde Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Marchand more than expected).

Fields of papers citing papers by Mathilde Marchand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Marchand. The network helps show where Mathilde Marchand may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathilde Marchand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathilde Marchand Line = papers co-authored together Mathilde Marchand links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Hit paper breakdown →
2020589
2
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Hit paper breakdown →
2021229
3 2016136
4 2020124
5 202298
6 201976
7 201661
8 202128
9 202127
10 201525
11 202123
12 201717
13 202315
14 202212
15 20249
16 20258
17 20227
18 20226
19 20236
20 20235

About Mathilde Marchand

Mathilde Marchand is a scholar working on Oncology, Immunology, Transplantation, Radiology, Nuclear Medicine and Imaging and Modeling and Simulation, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (2 papers), Organ and Tissue Transplantation Research (2 papers), Immunotherapy and Immune Responses (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Infectious Diseases (642 citations), Neurology (319 citations), Oncology (362 citations), Critical Care and Intensive Care Medicine (44 citations) and Immunology (165 citations). Mathilde Marchand has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include René Bruno, Sandhya Girish, Jin Y. Jin, Helen R. Winter, Benjamin M. Wu, Stephen Eppler, Phyllis Chan, Mark Stroh, Jane Ruppel and Oyewale O. Abidoye. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacology & Therapeutics, JAMA Internal Medicine and Clinical and Translational Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact